Compare Ambarella Inc (AMBA) vs Vital Farms Inc (VITL) Price & Performance

Ambarella (AMBA) trades at $77.30, down 1.38% on the day, with a bullish technical setup supported by moving averages and key resistance at $81. The company reported three consecutive quarterly EPS beats, with Q1 2027 earnings of $0.11 meeting estimates, while revenue grew 16.9% year-over-year to $100.4 million. A major catalyst is the $800+ million long-term edge AI agreement with Hanwha, signaling strong demand in physical AI markets. However, net income remains negative at -$117.13 million for 2025, though margins are improving.

Outlook: Wall Street is bullish with a $108.67 consensus price target (40% upside), driven by edge AI adoption and auto sector growth. Risks include persistent losses, competitive pressure from larger chipmakers, and execution challenges in scaling new AI contracts. The stock's valuation at 8.21x sales appears reasonable if revenue acceleration continues, but profitability remains key for sustained gains.

Vital Farms (VITL) trades at $12.95, down 0.08% on the day, with a bullish technical signal supported by moving averages but overbought RSI readings. The stock shows solid profitability with a 6.1% net margin and 15.44% ROE, though earnings missed expectations in two recent quarters. Valuation appears reasonable with a P/E of 12.45 and P/S of 0.75. Recent news highlights volatility, including a class-action lawsuit filed in May 2026, while cash flow trends indicate significant investing outflows.

The outlook is mixed: analyst consensus leans bullish with a $13.50 price target, but risks include legal overhangs, earnings volatility, and negative cash flow. Revenue growth is modest, projected at $784M for 2026, but profit margins are declining. Investors should weigh strong fundamentals against near-term headwinds from litigation and operational challenges.